Canadian College of Medical Geneticists guidelines for the indications, analysis, and reporting of cancer specimens

Current Oncology

Volumn 18, Issue 5, 2011, Pages

  Dawson, A J ^a   McGowan Jordan, J ^b   Chernos, J ^c   Xu, J ^d   Lavoie, J ^e   Wang, J C ^f   Steinraths, M ^g   Shetty, S ^h  

^a Diagnostic Services of Manitoba Inc   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c ALBERTA CHILDREN'S HOSPITAL   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e MONTREAL CHILDREN S HOSPITAL   (Canada)

^f LONDON HEALTH SCIENCES CENTRE   (Canada)

^g VICTORIA GENERAL HOSPITAL   (Canada)

^h ARUP LABORATORIES   (United States)

Author keywords

Cancer; Cytogenetics; Hematopoietic; Lymphoid; Tumours

Indexed keywords

ACUTE LEUKEMIA; ATYPICAL CHRONIC MYELOID LEUKEMIA; BONE MARROW TUMOR; CANADA; CANCER GENETICS; CHROMOSOME ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; EOSINOPHILIA; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC SERVICE; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HUMAN; LARGE CELL LYMPHOMA; LYMPHATIC SYSTEM TUMOR; MEDICAL GENETICS; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; PROLYMPHOCYTIC LEUKEMIA; REVIEW; SEX CHROMOSOME ABERRATION; SOLID TUMOR; T CELL LYMPHOMA; TISSUE SECTION;

EID: 80053628852     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v18i5.775     Document Type: Review

References (8)

1. Swerdlow SH, Campo E, Harris NL, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: iarc Press; 2008: 1-439.
2. American College of Medical Genetics (acmg). Standards and Guidelines for Clinical Genetics Laboratories. 3rd ed. Bethesda, MD: acmg; 2006. [Available online at: http://www.acmg.net/Pages/acmg_Activities/stds-2002/stdsmenu-n.htm; cited: July 14, 2010]
3. Swansbury GJ. The proportion of clonal divisions varies in different hematologic malignancies. The United Kingdom Cancer Cytogenetics Group (ukccg) [corrected]. Cancer Genet Cytogenet 1998;104:139-45.
4. Kuffel DG, Schultz CG, Ash RC, Dewald GW. Normal cytogenetic values for bone marrow based on studies of bone marrow transplant donors. Cancer Genet Cytogenet 1991;55:39-48.
5. Shaffer LG, Slovak ML, Campbell LJ, eds. An International System for Human Cytogenetic Nomenclature 2009. Basel, Switzerland: S. Karger AG; 2009.
6. Dewald GW, Schad CR, Christensen ER, et al. Fluorescence in situ hybridization with X or Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation. Bone Marrow Transplant 1993;12:149-54.
7. Dewald G, Stallard R, Al Saadi A, et al. Multicenter investigation with interphase fluorescence in situ hybridization using Xand Y-chromosome probes. Am J Med Genet 1998;76:318-26.
8. Dewald G, Stallard R, Alsaadi A, et al. A multicenter investigation with d-fish BCR/ABL1 probes. Cancer Genet Cytogenet 2000;116:97-104.